RTW Investments bought 16,010,524 shares of Erasca last quarter, an estimated $189.23 million transaction based on the quarter's average share price. The move is notable as a large institutional purchase in a biotech name, but the article provides no operational or earnings update. Overall impact is likely limited unless followed by additional buying or company-specific catalysts.
RTW Investments bought 16,010,524 shares of Erasca last quarter, an estimated $189.23 million transaction based on the quarter's average share price. The move is notable as a large institutional purchase in a biotech name, but the article provides no operational or earnings update. Overall impact is likely limited unless followed by additional buying or company-specific catalysts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.08
Ticker Sentiment